FiercePharma: FDA set to work with insurers, PBMs to fight opioid crisis

FiercePharma: FDA set to work with insurers, PBMs to fight opioid crisis

PCMA CEO Mark Merritt wrote a Monday letter to Gottlieb outlining some measures for consideration in advance of the talks. Among them are a 7-day prescription limit for acute pain and increased tools to fight fraud.